<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="general-sciences" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1892</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>General Sciences</subject></subj-group></article-categories><title-group><article-title>AN INVITRO STUDY OF CISPLATIN INDUCED NEPHROTOXICITY IN GOAT KIDNEY&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>.Sangeetha</surname><given-names>N</given-names></name></contrib></contrib-group><volume/><issue/><fpage>119</fpage><lpage>126</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Cisplatin (CP) is one of the most active cytotoxic agents in the treatment of cancer and has adverse side effects such as nephrotoxicity and hepatotoxicity. The present study was designed to determine the cisplatin induced nephrotoxicity by determining Urea, Creatinine, Malondialdehyde (MDA), reduced glutathione (GSH), Glutathione peroxidase (GPx), Superoxide dismutase (SOD) and Catalase (CAT) in goat kidney homogenates. A significantly (p__ampersandsignlt;0.02) increase in Urea and Creatinine was found. In addition, there was significant (p__ampersandsignlt;0.001) increase of MDA. But no significant difference in the non-enzymic antioxidant GSH in CP treated tissue homogenate but a less significant (p__ampersandsignlt;0.2) decrease in GPx and significant (p__ampersandsignlt;0.001) decrease in SOD and CAT was observed. Thus, excessive ROS production by CP causes an antioxidant imbalance which leads to lipid peroxidation and antioxidant depletion. In conclusion, CP treatment induces an irreversible kidney injury.&#13;
</p></abstract><kwd-group><kwd>Cisplatin</kwd><kwd> Nephrotoxicity</kwd><kwd> Oxidative stress</kwd><kwd> Antioxidant enzymes.</kwd></kwd-group></article-meta></front></article>
